收稿日期: 2022-05-14
录用日期: 2022-11-03
网络出版日期: 2023-01-16
基金资助
国家自然科学基金(82172159);上海交通大学医工交叉研究基金(YG2021QN56)
Progress of residual neuromuscular blockade after general anesthesia in elderly patients
Received date: 2022-05-14
Accepted date: 2022-11-03
Online published: 2023-01-16
Supported by
National Natural Science Foundation of China(82172159);Interdisciplinary Program of Shanghai Jiao Tong University(YG2021QN56)
肌肉松弛（肌松）药诱导的肌肉松弛是手术中气管插管和固定的重要条件之一，术后未完全逆转肌松药效应称为术后肌松残余（postoperative residual neuromuscular block，PRNB）。PRNB可引发患者一系列严重的术后并发症甚至死亡，因此在麻醉实施过程中对其进行早期预防及积极治疗必不可少。随着外科技术飞速发展及人口平均寿命逐渐延长，老年患者的手术需求逐渐增多。与此同时，由于老年患者机体的生理病理变化及合并的基础疾病，其更易发生不同程度的PRNB，可严重损害患者的预后以及增加医疗资源的损耗。近年来，各类短效肌松药和新型拮抗剂（如舒更葡糖钠）等的问世，以及术中肌松监测的临床应用，已经明显降低了年龄相关PRNB所致不良事件的发生率，彻底改变了麻醉实践。同时，以神经肌肉接头结构为主导的基础研究，以及针对老年患者的药代动力学和药效动力学研究，也为降低PRNB对老年患者的危害提供了新的理论依据。该文对临床上老年患者全身麻醉手术后发生PRNB的原因机制、引发的不良事件及临床干预措施的研究进展作一综述，以期为老年患者全身麻醉的肌松管理及术后拮抗提供参考。
刘秋利 , 江来 , 翁晓建 . 老年患者全身麻醉术后肌松残余的研究进展[J]. 上海交通大学学报（医学版）, 2023 , 43(1) : 108 -113 . DOI: 10.3969/j.issn.1674-8115.2023.01.014
Muscle relaxation induced by muscle relaxants is one of the important conditions for endotracheal intubation and fixation, but sometimes muscle functions recover incompletely after operations, which is called postoperative residual neuromuscular block (PRNB). It can cause a series of serious postoperative complications and even death. Hence, it is essential to prevent and treat PRNB in the early stage during anesthesia implementation. With the rapid development of surgical technology and the gradual extension of the life span of the population, the number of operations for elderly patients is gradually increasing. Meanwhile, due to the physiological and pathological changes of the elderly and the combined underlying diseases, the elderly are more likely to suffer from PRNB in different degrees after surgery, which seriously damages the prognosis of elderly patients and increases the loss of medical resources. In these years, the successful application of short-acting muscle relaxants, new antagonists (such as sugammadex), and multi-mode neuromuscular monitoring devices in clinical practice have greatly reduced the incidence of PRNB in elderly patients. Furthermore, the basic researches which mainly based on the neuromuscular junction structure and the pharmacokinetic and pharmacodynamic studies of the elderly provide a new theoretical basis for reducing the harm of PRNB to elderly patients. This paper reviews the research progress of the mechanism, adverse events and clinical interventions of PRNB in elderly patients after general anesthesia surgeries to provide reference for muscle relaxation management and postoperative antagonism in these people.
| 1 | BLOOM D E, CHATTERJI S, KOWAL P, et al. Macroeconomic implications of population ageing and selected policy responses[J]. Lancet, 2015, 385(9968): 649-657. |
| 2 | CAO X Z, WHITE P F, MA H. Perioperative care of elderly surgical outpatients[J]. Drugs Aging, 2017, 34(9): 673-689. |
| 3 | 吴新民. 麻醉过程中使用肌松药及其拮抗剂的必要性[J]. 临床药物治疗杂志, 2019, 17(6): 32-34, 80. |
| 3 | WU X M. The necessity for using muscle relaxants and their antagonists during anesthesia[J]. Clinical Medication Journal, 2019, 17(6): 32-34, 80. |
| 4 | CARRON M, BERTONCELLO F, IEPPARIELLO G. Profile of sugammadex for reversal of neuromuscular blockade in the elderly: current perspectives[J]. Clin Interv Aging, 2017, 13: 13-24. |
| 5 | COPE T M, HUNTER J M. Selecting neuromuscular-blocking drugs for elderly patients[J]. Drugs Aging, 2003, 20(2): 125-140. |
| 6 | WEIGEL W A, WILLIAMS B L, HANSON N A, et al. Quantitative neuromuscular monitoring in clinical practice: a professional practice change initiative[J]. Anesthesiology, 2022, 136(6): 901-915. |
| 7 | NAGUIB M, BRULL S J, KOPMAN A F, et al. Consensus statement on perioperative use of neuromuscular monitoring[J]. Anesth Analg, 2018, 127(1): 71-80. |
| 8 | MURPHY G S, SZOKOL J W, AVRAM M J, et al. Residual neuromuscular block in the elderly: incidence and clinical implications[J]. Anesthesiology, 2015, 123(6): 1322-1336. |
| 9 | GRABITZ S D, RAJARATNAM N, CHHAGANI K, et al. The effects of postoperative residual neuromuscular blockade on hospital costs and intensive care unit admission: a population-based cohort study[J]. Anesth Analg, 2019, 128(6): 1129-1136. |
| 10 | BASH L D, TURZHITSKY V, BLACK W, et al. Neuromuscular blockade and reversal agent practice variability in the US inpatient surgical settings[J]. Adv Ther, 2021, 38(9): 4736-4755. |
| 11 | THOMSEN J L D, MATHIESEN O, H?GI-PEDERSEN D, et al. Improving neuromuscular monitoring and reducing residual neuromuscular blockade via e-learning: a multicentre interrupted time-series study (INVERT study)[J]. Acta Anaesthesiol Scand, 2022, 66(5): 580-588. |
| 12 | MURPHY G S, BRULL S J. Quantitative neuromuscular monitoring and postoperative outcomes: a narrative review[J]. Anesthesiology, 2022, 136(2): 345-361. |
| 13 | WEIGEL W A, THILEN S R. Neuromuscular blockade monitoring and reversal: a clinical and pharmacoeconomic update[J]. Adv Anesth, 2021, 39: 169-188. |
| 14 | KHAN M S, ROBERTS M S. Challenges and innovations of drug delivery in older age[J]. Adv Drug Deliv Rev, 2018, 135: 3-38. |
| 15 | WANG H, CHAI K, DU M H, et al. Prevalence and incidence of heart failure among urban patients in China: a national population-based analysis[J]. Circ Heart Fail, 2021, 14(10): e008406. |
| 16 | DI CESARE F, TENORI L, MEONI G, et al. Lipid and metabolite correlation networks specific to clinical and biochemical covariate show differences associated with sexual dimorphism in a cohort of nonagenarians[J]. GeroScience, 2022, 44(2): 1109-1128. |
| 17 | MINA D A, JOHANSEN K L, MCCULLOCH C E, et al. Muscle relaxant use among hemodialysis patients: prevalence, clinical indications, and adverse outcomes[J]. Am J Kidney Dis, 2019, 73(4): 525-532. |
| 18 | JOHARATNAM-HOGAN N, SHIU K K, KHAN K. Challenges in the treatment of gastric cancer in the older patient[J]. Cancer Treat Rev, 2020, 85: 101980. |
| 19 | SUN S J, SUN Y, CHEN R, et al. Diaphragm ultrasound to evaluate the antagonistic effect of sugammadex on rocuronium after liver surgery in patients with different liver Child-Pugh grades: study protocol for a prospective, double-blind, non-randomised controlled trial[J]. BMJ Open, 2022, 12(2): e052279. |
| 20 | LIU H, WENG X J, YAO J Y, et al. Neuregulin-1β protects the rat diaphragm during sepsis against oxidative stress and inflammation by activating the PI3K/Akt pathway[J]. Oxid Med Cell Longev, 2020, 2020: 1720961. |
| 21 | LIU H, WU J, YAO J Y, et al. The role of oxidative stress in decreased acetylcholinesterase activity at the neuromuscular junction of the diaphragm during sepsis[J]. Oxid Med Cell Longev, 2017, 2017: 9718615. |
| 22 | STEWART P A, LIANG S S, LI Q S, et al. The impact of residual neuromuscular blockade, oversedation, and hypothermia on adverse respiratory events in a postanesthetic care unit: a prospective study of prevalence, predictors, and outcomes[J]. Anesth Analg, 2016, 123(4): 859-868. |
| 23 | NATARAJAN S, GOVENDER K, SHOBO A, et al. Potential of brain mast cells for therapeutic application in the immune response to bacterial and viral infections[J]. Brain Res, 2021, 1767: 147524. |
| 24 | GUO J R, YUAN X H, ZHOU X F, et al. Pharmacokinetics and pharmacodynamics of cisatracurium in patients undergoing surgery with two hemodilution methods[J]. J Clin Anesth, 2017, 38: 75-80. |
| 25 | UEYAMA S, HAYAMA S, MIZUTANI M, et al. Periodic quadriplegia during the acute postoperative phase of cervical laminoplasty: a case report and literature review[J]. Acta Neurochir (Wien), 2022, 164(5): 1229-1232. |
| 26 | MEDINA M, TUFIK S, ANDERSEN M L. Sleep disturbances and residual neuromuscular blockade: future research possibilities[J]. Anaesthesia, 2020, 75(4): 552. |
| 27 | CEDBORG A I, SUNDMAN E, BODéN K, et al. Pharyngeal function and breathing pattern during partial neuromuscular block in the elderly: effects on airway protection[J]. Anesthesiology, 2014, 120(2): 312-325. |
| 28 | ALENEZI F K, ALNABABTAH K, ALQAHTANI M M, et al. The association between residual neuromuscular blockade (RNMB) and critical respiratory events: a prospective cohort study[J]. Perioper Med (Lond), 2021, 10(1): 14. |
| 29 | KIRMEIER E, ERIKSSON L I, LEWALD H, et al. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study[J]. Lancet Respir Med, 2019, 7(2): 129-140. |
| 30 | BLOBNER M, HUNTER J M, MEISTELMAN C, et al. Use of a train-of-four ratio of 0.95 versus 0.9 for tracheal extubation: an exploratory analysis of POPULAR data[J]. Br J Anaesth, 2020, 124(1): 63-72. |
| 31 | DAHABA A A, SULJEVIC I, OETTL K, et al. Influence of acute normovolemic hemodilution on the pharmacokinetics of cisatracurium besylate[J]. Minerva Anestesiol, 2013, 79(11): 1238-1247. |
| 32 | LI G, FREUNDLICH R E, GUPTA R K, et al. Postoperative pulmonary complications′ association with sugammadex versus neostigmine: a retrospective registry analysis[J]. Anesthesiology, 2021, 134(6): 862-873. |
| 33 | SUN Y, WU Z L, WANG Q, et al. Sugammadex, the guardian of deep muscle relaxation during conventional and robot-assisted laparoscopic surgery: a narrative review[J]. Drug Des Devel Ther, 2021, 15: 3893-3901. |
| 34 | RAUCH S, MILLER C, BR?UER A, et al. Perioperative hypothermia: a narrative review[J]. Int J Environ Res Public Health, 2021, 18(16): 8749. |
| 35 | J?TC? G, ?SZ B E, TERO-VESCAN A, et al. Positive aspects of oxidative stress at different levels of the human body: a review[J]. Antioxidants (Basel), 2022, 11(3): 572. |
| 36 | SUZUKI K, TAKAZAWA T, SAITO S. History of the development of antagonists for neuromuscular blocking agents[J]. J Anesth, 2020, 34(5): 723-728. |
| 37 | GUIHARD B, CHOLLET-XéMARD C, LAKHNATI P, et al. Effect of rocuronium vs succinylcholine on endotracheal intubation success rate among patients undergoing out-of-hospital rapid sequence intubation: a randomized clinical trial[J]. JAMA, 2019, 322(23): 2303-2312. |
| 38 | SOLTéSZ S, ALM P, MATHES A, et al. The effect of neuromuscular blockade on the efficiency of facemask ventilation in patients difficult to facemask ventilate: a prospective trial[J]. Anaesthesia, 2017, 72(12): 1484-1490. |
| 39 | VAN HEES M, SLOTT S, HANSEN A H, et al. New approaches to moderate CRISPR-Cas9 activity: addressing issues of cellular uptake and endosomal escape[J]. Mol Ther, 2022, 30(1): 32-46. |
| 40 | The National Heart, Lung, and Blood Institute PETAL Clinical Trials Network. Early neuromuscular blockade in the acute respiratory distress syndrome[J]. N Engl J Med, 2019, 380(21): 1997-2008. |
| 41 | KAULLEN J D, OWEN J S, BROUWER K L R, et al. Pharmacokinetic/pharmacodynamic model of CW002, an investigational intermediate neuromuscular blocking agent, in healthy volunteers[J]. Anesthesiology, 2018, 128(6): 1107-1116. |
| 42 | RENEW J R, RATZLAFF R, HERNANDEZ-TORRES V, et al. Neuromuscular blockade management in the critically ill patient[J]. J Intensive Care, 2020, 8: 37. |
| 43 | CHOI E S, OH A Y, SEO K S, et al. Optimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracurium[J]. Anaesthesia, 2016, 71(4): 443-449. |
| 44 | JI W T, ZHANG X T, LIU J, et al. Efficacy and safety of neostigmine for neuromuscular blockade reversal in patients under general anesthesia: a systematic review and meta-analysis[J]. Ann Transl Med, 2021, 9(22): 1691. |
| 45 | DOMENECH G, KAMPEL M A, GARCíA GUZZO M E, et al. Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study[J]. BMC Anesthesiol, 2019, 19(1): 143. |
| 46 | DENG J, BALOUCH M, ALBRINK M, et al. Sugammadex reduces PACU recovery time after abdominal surgery compared with neostigmine[J]. South Med J, 2021, 114(10): 644-648. |
| 47 | 余承晏, 薛庆生, 于布为. 新型肌肉松弛药拮抗剂布瑞亭的临床研究进展[J]. 上海医学, 2018, 41(3): 185-189. |
| 47 | YU C Y, XUE Q S, YU B W. Progress in clinical research of a new muscle relaxant antagonist brettine[J]. Shanghai Medical Journal, 2018, 41(3): 185-189. |
| 48 | HAN J, RYU J H, KOO B W, et al. Effects of sugammadex on post-operative pulmonary complications in laparoscopic gastrectomy: a retrospective cohort study[J]. J Clin Med, 2020, 9(4): 1232. |
| 49 | OLESNICKY B L, TRUMPER R, CHEN V, et al. The use of sugammadex in critical events in anaesthesia: a retrospective review of the webAIRS database[J]. Anaesth Intensive Care, 2022, 50(3): 220-226. |
| 50 | ORIHARA M, TAKAZAWA T, HORIUCHI T, et al. Comparison of incidence of anaphylaxis between sugammadex and neostigmine: a retrospective multicentre observational study[J]. Br J Anaesth, 2020, 124(2): 154-163. |
| 51 | DE BOER H D, CARLOS R V. New drug developments for neuromuscular blockade and reversal: gantacurium, CW002, CW011, and calabadion[J]. Curr Anesthesiol Rep, 2018, 8(2): 119-124. |
| 52 | THEVATHASAN T, GRABITZ S D, SANTER P, et al. Calabadion 1 selectively reverses respiratory and central nervous system effects of fentanyl in a rat model[J]. Br J Anaesth, 2020, 125(1): e140-e147. |
| 53 | HAERTER F, SIMONS J C P, FOERSTER U, et al. Comparative effectiveness of calabadion and sugammadex to reverse non-depolarizing neuromuscular-blocking agents[J]. Anesthesiology, 2015, 123(6): 1337-1349. |
| 54 | LIM G, LANDSITTEL D P. Effectiveness versus efficacy of calabadion and sugammadex for nondepolarizing neuromuscular blocking agent reversal[J]. Anesthesiology, 2016, 124(6): 1417. |
/
| 〈 |
|
〉 |